Intestinal permeability measurements: General aspects and possible pitfalls;Mediciones de permeabilidad intestinal: Aspectos generales y posibles riesgos

Nutricion Hospitalaria

Volumn 29, Issue 2, 2014, Pages 269-281

  Teixeira, Tatiana Fiche Salles ^a   Boroni Moreira, Ana Paula ^a   Souza, Nilian Carla Silva ^b   Frias, Rafael ^c   Gouveia Peluzio, Maria do Carmo ^a  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Gut barrier; Intestinal permeability; Lactulose; Mannitol

Indexed keywords

HUMAN; INTESTINE ABSORPTION; PERMEABILITY; PHYSIOLOGY; TIGHT JUNCTION;

HUMANS; INTESTINAL ABSORPTION; PERMEABILITY; TIGHT JUNCTIONS;

EID: 84896877397     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2014.29.2.7076     Document Type: Review

References (146)

1. Shen L, Su L, Turner JR. Mechanisms and functional implications of intestinal barrier defects. Dig Dis 2009; 27: 443-9.
2. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009; 9: 799-809.
3. Menard S, Cerf-Bensussan N, Heyman M. Multiple facets of intestinal permeability and epithelial handling of dietary antigens. Mucosal Immunol 2010; 3: 247-59.
4. Scaldaferri F, Pizzoferrato M, Gerardi V, Lopetuso L, Gasbarrini A. The gut barrier: new acquisitions and therapeutic approaches. J Clin Gastroenterol 2012; 46: S12-S7.
5. Buret AG. How stress induces intestinal hypersensitivity. Am J Pathol 2006; 168: 3-5.
6. Fasano A. Leaky gut and autoimmune diseases. Clin Rev Allergy Immunol 2012; 42: 71-8.
7. Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002; 123: 450-60.
8. Bjarnason I, Macpherson A, Hollander D. Intestinal permeability: An overview. Gastroenterology 1995; 108: 1566-81.
9. Farhadi A, Banan ALI, Fields J, Keshavarzian ALI. Intestinal barrier: An interface between health and disease. J Gastroenterol Hepatol 2003; 18: 479-97.
10. Pirlich M, Norman K, Lochs H, Bauditz J. Role of intestinal function in cachexia. Curr Opin Clin Nutr Metab Care 2006; 9: 603-6.
11. Karaeren Z, Akbay A, Demirtas S, Ergüder Í, Özden A. A reference interval study of urinary lactulose excretion: a useful test of intestinal permeability in adults. Turk J Gastroenterol 2002; 13: 35-9.
12. Paroni R, Fermo I, Molteni L, Folini L, Pastore MR, Mosca A et al. Lactulose and mannitol intestinal permeability detected by capillary electrophoresis. J Chromatogr B 2006; 834: 183-7.
13. Lostia AM, Lionetto L, Principessa L, Evangelisti M, Gamba A, Villa MP et al. A liquid chromatography/mass spectrometry method for the evaluation of intestinal permeability. Clinical Biochemistry 2008; 41: 887-92.
14. Duerksen DR, Wilhelm-Boyles C, Parry DM. Intestinal permeability in long-term follow-up of patients with celiac disease on a gluten-free diet. Dig Dis Sci 2005; 50: 785-90.
15. Uil JJ, van Elburg RM, van Overbeek FM, Mulder CJ, VanBerge-Henegouwen GP, Heymans HS. Clinical implications of the sugar absorption test: intestinal permeability test to assess mucosal barrier function. Scand J Gastroenetrol Suppl 1997; 223: 70-8.
16. Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut 2006; 55: 1512-20.
17. Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 2011; 141: 769-76.
18. Matter K, Balda MS. Signalling to and from tight junctions. Nature Rev 2003; 4: 225-36.
19. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57: 1470-81.
20. Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 2009; 49: 1877-87.
21. Vilela E, Torres HOG, Ferrari MLA, Lima AS, Cunha A. Gut permeability to lactulose and mannitol differs in treated Crohn's disease and celiac disease patients and healthy subjects. Braz J Med Biol Res 2008; 41: 1105-9.
22. Teshima C, Meddings J. The measurement and clinical significance of intestinal permeability. Curr Gastroenterol Rep 2008; 10: 443-9.
23. Watson AJM, Duckworth CA, Guan Y, Montrose MH. Mechanisms of epithelial cell shedding in the mammalian intestine and maintenance of barrier function. Ann N Y Acad Sci 2009; 1165: 135-42.
24. Camilleri M, Nadeau A, Lamsam J, Linker Nord S, Ryks M, Burton D et al. Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion. Neurogastroenterol Motil 2010; 22: e15-e26.
25. Uil JJ, VanElburg RM, VanOverbeek FM, Mulder CJJ, VanbergeHenegouwen GP, Heymans HSA. Clinical implications of the sugar absorption test: Intestinal permeability test to assess mucosal barrier function. Scand J Gastroenterol 1997; 32: 70-8.
26. Meddings JB, Sutherland LR, Byles NI, Wallace JL. Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology 1993; 104: 1619-26.
27. Meddings JB, Gibbons I. Discrimination of site-specific alterations in gastrointestinal permeability in the rat. Gastroenterology 1998; 114: 83-92.
28. Farhadi A, Keshavarzian A, Holmes EW, Fields J, Zhang L, Banan A. Gas chromatographic method for detection of urinary sucralose: application to the assessment of intestinal permeability. J Chromatogr B 2003; 784: 145-54.
29. Anderson ADG, Jain PK, Fleming S, Poon P, Mitchell CJ, MacFie J. Evaluation of a triple sugar test of colonic permeability in humans. Acta Physiol Scand 2004; 182: 171-7.
30. McOmber ME, Ou C-N, Shulman RJ. Effects of timing, sex, and age on site-specific gastrointestinal permeability testing in children and adults. J Pediatr Gastroenterol Nutr 2010; 50: 269-75.
31. Akram S, Mourani S, Ou C-N, Rognerud C, Sadiq R, Goodgame R. Assessment of intestinal permeability with a two-hour urine collection. Dig Dis Sci 1998; 43: 1946-50.
32. Cox MA, Iqbal TH, Cooper BT, Lewis KO. An analytical method for the quantitation of mannitol and disaccharides in serum: a potentially useful technique in measuring small intestinal permeability in vivo. Clin Chim Acta 1997; 263: 197-205.
33. Fleming SC, Duncan A, Russell RI, Laker MF. Measurement of sugar probes in serum: an alternative to urine measurement in intestinal permeability testing. Clin Chem 1996; 42: 445-8.
34. Martínez-Augustin O, Boza JJ, Romera JM, Gil A. A rapid gasliquid chromatography method for the determination of lactulose and mannitol in urine: Clinical application in studies of intestinal permeability. Clin Biochem 1995; 28: 401-5.
35. Van Der Hulst RRWJ, Von Meyenfeldt MF, Van Kreel BK, Thunnissen FBJM, Brummer R-JM, Arends J-W et al. Gut permeability, intestinal morphology, and nutritional depletion. Nutrition 1998; 14: 1-6.
36. Dastych M, Dastych M Jr, Novotná H, Cíhalová J. Lactulose/mannitol test and specificity, sensitivity, and area under curve of intestinal permeability parameters in patients with liver cirrhosis and Crohn's disease. Dig Dis Sci 2008; 53: 2789-92.
37. Marsilio R, D'Antiga L, Zancan L, Dussini N, Zacchello F. Simultaneous HPLC determination with light-scattering detection of lactulose and mannitol in studies of intestinal permeability in pediatrics. Clin Chem 1998; 44: 1685-91.
38. Bjarnason I, Takeuchi K. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy. J Gastroenterol 2009; 44: 23-9.
39. Smecuol E, Pinto Sanchez MI, Suarez A, Argonz JE, Sugai E, Vazquez H et al. Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment. Clin Gastroenterol Hepatol 2009; 7: 524-9.
40. Purohit V, Bode JC, Bode C, Brenner DA, Choudhry MA, Hamilton F et al. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: Summary of a symposium. Alcohol 2008; 42: 349-61.
41. Kavanaugh MJ, Clark C, Goto M, Kovacs EJ, Gamelli RL, Sayeed MM et al. Effect of acute alcohol ingestion prior to burn injury on intestinal bacterial growth and barrier function. Burns 2005; 31: 290-6.
42. Pals KL, Chang R-T, Ryan AJ, Gisolfi CV. Effect of running intensity on intestinal permeability. J Appl Physiol 1997; 82: 571-6.
43. Söderholm JD, Perdue MH. II. Stress and intestinal barrier function. Am J Physiol Gastrointest Liver Physiol 2001; 280: G7-G13.
44. Saunders P, Santos J, Hanssen NM, Yates D, Groot J, Perdue M. Physical and psychological stress in rats enhances colonic epithelial permeability via peripheral CRH. Dig Dis Sci 2002; 47: 208-15.
45. Peeters M, Geypens B, Claus D, Nevens H, Ghoos Y, Verbeke G et al. Clustering of increased small intestinal permeability in families with Crohn's disease. Gastroenterology 1997; 113: 802-7.
46. May GR, Sutherland LR, Meddings JB. Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology 1993; 104: 1627-32.
47. Hollander D. Permeability in Crohn s disease: altered barrier functions in healthy relatives? Gastroenterology 1993; 104: 1848-51.
48. Travis S, Menzies I. Intestinal permeability: functional assessment and significance. Clin Sci 1992; 82: 471-88.
49. Berkes J, Viswanathan VK, Savkovic SD, Hecht G. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 2003; 52: 439-51.
50. Celli M, D'Eufemia P, Dommarco R, Finocchiaro R, Aprigliano D, Martino F et al. Rapid gas-chromatographic assay of lactulose and mannitol for estimating intestinal permeability. Clin Chem 1995; 41: 752-6.
51. Farhadi A, Keshavarzian A, Fields JZ, Sheikh M, Banan A. Resolution of common dietary sugars from probe sugars for test of intestinal permeability using capillary column gas chromatography. J Chromatogr B 2006; 836: 63-8.
52. Mattioli F, Fucile C, Marini V, Isola L, Montanaro F, Savarino V et al. Assessment of intestinal permeability using sugar probes: influence of urinary volume. Clin Lab 2011; 57: 909-18.
53. Lin HC, Elashoff JD, Kwok GM, Gu YG, Meyer JH. Stimulation of duodenal motility by hyperosmolar mannitol depends on local osmoreceptor control. Am J Physiol Gastrointest Liver Physiol 1994; 266: G940-G3.
54. Barboza Jr MS, Silva TMJ, Guerrant RL, Lima AAM. Measurement of intestinal permeability using mannitol and lactulose in children with diarrheal diseases. Braz J Med Biol Res 1999; 32: 1499-504.
55. Maduka IC, Neboh EE, Shu EN, Ikekpeazu EJ. Drug dosing in adult and paediatric population in developing countries: possible pharmaceutical misadventure. Br J Pharm Toxicol 2010; 1: 77-80.
56. Bosma RJ, Homan JJ, Heide vd, Oosterop EJ, Jong PEd, Navis G. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int 2004; 65: 259-65.
57. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y. The Effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003; 14: 1480-6.
58. Agarwal R. Estimating GFR from serum creatinine concentration: Pitfalls of GFR-estimating equations. Am J Kidney Dis 2005; 45: 610-3.
59. Verhave JC, Fesler P, Ribstein J, du Cailar G, Mimran A. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 2005; 46: 233-41.
60. Saltzman JR, Kowdley KV, Perrone G, Russell RM. Changes in small intestine permeability with aging. J Am Geriatr Soc 1995; 43: 160-4.
61. Teixeira TFS, Souza NCS, Chiarello PG, Franceschini SCC, Bressan J, Ferreira CLLF et al. Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin Nutr 2012; 31: 735-40.
62. Odenwald MA, Turner JR. Intestinal permeability defects: is it time to treat? Clin Gastroenterol Hepatol 2013.
63. Ferraris RP, Vinnakota RR. Intestinal nutrient transport in genetically obese mice. Am J Clin Nutr 1995; 62: 540-6.
64. Verdam FJ, Greve JWM, Roosta S, van Eijk H, Bouvy N, Buurman WA et al. Small intestinal alterations in severely obese hyperglycemic subjects. JCEM 2011; 96: E379-E83.
65. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840-6.
66. McRoberts JA, Aranda R, Riley N, Kang H. Insulin regulates the paracelular permeability of cultured intestinal epithelial cell monolayers. J Clin Invest 1990; 85: 1127-34.
67. Hilsden RJ, Meddings JB, Sutherland LR. Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. Gastroenterology 1996; 110: 1395-403.
68. Farhadi A, Gundlapalli S, Shaikh M, Frantzides C, Harrell L, Kwasny MM et al. Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis. Liver Int 2008; 28: 1026-33.
69. Vojdani A. For the assessment of intestinal permeability, size matters. Altern Ther Health Med 2013; 19: 12-24.
70. Dibaise JK, Young RJ, Vanderhoof JA. Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome. Clin Gastroenterol Hepatol 2006; 4: 11-20.
71. Derikx JPM, Luyer MDP, Heineman E, Buurman WA. Non-invasive markers of gut wall integrity in health and disease. World J Gastroenterol 2010; 16: 5272-9.
72. Talasniemi JP, Pennanen S, Savolainen H, Niskanen L, Liesivuori J. Analytical investigation: Assay of d-lactate in diabetic plasma and urine. Clin Biochem 2008; 41: 1099-103.
73. Çǎglayan F, Çakmak M, Çǎglayan O, Çavusoglu T. Plasma dlactate levels in diagnosis of appendicitis. J Invest Surg 2003; 16: 233-7.
74. Batista MA, Nicoli JR, dos Santos Martins F, Nogueira Machado JA, Esteves Arantes RM, Pacífico Quirino IE et al. Pretreatment with citrulline improves gut barrier after intestinal obstruction in mice. JPEN 2012; 36: 69-76.
75. Blijlevens NMA, Lutgens LCHW, Schattenberg AVMB, Donnelly JP. Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy. Bone Marrow Transplant 2004; 34: 193-6.
76. Elwafi F, Curis E, Zerrouk N, Neveux N, Chaumeil J-C, Arnaud P et al. Endotoxemia affects citrulline, arginine and glutamine bioavailability. Eur J Clin Invest 2012; 42: 282-9.
77. Brun P, Castagliuolo I, Leo VD, Buda A, Pinzani M, Palù G et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007; 292: G518-G25.
78. Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007; 50: 2374-83.
79. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009; 58: 1091-103.
80. Crenn P, Messing B, Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr 2008; 27: 328-39.
81. Thuijls G, Derikx JPM, Haan J-Jd, Grootjans J, Bruïne Ad, Masclee AAM et al. Urine-based detection of intestinal tight junction loss. J Clin Gastroenterol 2010; 44: e14-e9.
82. Pelsers MMAL, Namiot Z, Kisielewski W, Namiot A, Januszkiewicz M, Hermens WT et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem 2003; 36: 529-35.
83. Grootjans J, Thuijls G, Verdam F, Derikx JPM, Lenaerts K, Buurman WA. Non-invasive assessment of barrier integrity and function of the human gut. World J Gastroenterol 2010; 2: 61-9.
84. Derikx JPM, Vreugdenhil ACE, Van den Neucker AM, Grootjans J, van Bijnen AA, Damoiseaux JGMC et al. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. J Clin Gastroenterol 2009; 43: 727-33.
85. Gisbert JP, McNicholl AG, Gomollon F. Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease. Inflamm Bowel Dis 2009; 15: 1746-54.
86. Konikoff MR, Denson LA. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Diss 2006; 12: 524-34.
87. Walker TR, Land ML, Kartashov A, Saslowsky TM, Lyerly DM, Boone JH et al. Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007; 44: 414-22.
88. Joishy M, Davies I, Ahmed M, Wassel J, Davies K, Sayers A et al. Fecal Calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2009; 48: 48-54.
89. Mania-Pramanik J, Potdar SS, Vadigoppula A, Sawant S. Elastase: A predictive marker of inflammation and/or infection. J Clin Lab Anal 2004; 18: 153-8.
90. Langhorst J, Elsenbruch S, Mueller T, Rueffer A, Spahn G, Michalsen A et al. Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis. Inflamm Bowel Dis 2005; 11: 1085-91.
91. Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev 2011; 91: 151-75.
92. Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS et al. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. PNAS 2009; 106: 16799-804.
93. Duerksen DR, Wilhelm-Boyles C, Veitch R, Kryszak D, Parry DM. A Comparison of antibody testing, permeability testing, and zonulin levels with small-bowel biopsy in celiac disease patients on a gluten-free diet. Dig Dis Sci 2010; 55: 1026-31.
94. Dupont C, Barau E, Molkhou P, Raynaud F, Barbet JP, Dehennin L. Food-induced alterations of intestinal permeability in children with cow's milk-sensitive enteropathy and atopic dermatitis. J Pediatr Gastroenterol Nutr 1989; 8: 459-65.
95. Hossain MI, Nahar B, Hamadani JD, Ahmed T, Roy AK, Brown KH. Intestinal mucosal permeability of severely underweight and non-malnourished Bangladeshi children, and effects of nutritional rehabilitation. J Pediatr Gastroenterol Nutr 2010; 51: 638-44.
96. Raj SM, Sein KT, Anuar AK, Mustaffa BE. Effect of intestinal helminthiasis on intestinal permeability of early primary schoolchildren. Trans Rl Soc Trop Med Hyg 1996; 90: 666-9.
97. Shulman RJ, Eakin MN, Czyzewski DI, Jarrett M, Ou C-N. Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome. J Pediatr 2008; 153: 646-50.
98. Ventura MT, Polimeno L, Amoruso AC, Gatti F, Annoscia E, Marinaro M et al. Intestinal permeability in patients with adverse reactions to food. Dig Liver Dis 2006; 38: 732-6.
99. Nagpal K, Minocha VR, Agrawal V, Kapur S. Evaluation of intestinal mucosal permeability function in patients with acute pancreatitis. Am J Surg 2006; 192: 24-8.
100. de la Maza MP, Gotteland M, Ramírez C, Araya M, Yudin T, Bunout D et al. Acute nutritional and intestinal changes after pelvic radiation. J Am Coll Nutr 2001; 20: 637-42.
101. Secondulfo M, Iafusco D, Carratù R, deMagistris L, Sapone A, Generoso M et al. Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients. Dig Liver Dis 2004; 36: 35-45.
102. Sapone A, de Magistris L, Pietzak M, Clemente MG, Tripathi A, Cucca F et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 2006; 55: 1443-9.
103. Sandek A, Bauditz J, Swidsinski A, Buhner S, Weber-Eibel J, von Haehling S et al. Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 2007; 50: 1561-9.
104. Goebel A, Buhner S, Schedel R, Lochs H, Sprotte G. Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome. Rheumatology 2008; 47: 1223-7.
105. Keshavarzian A, Holmes EW, Patel M, Iber F, Fields JZ, Pethkar S. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol 1999; 94: 200-7.
106. Cariello R, Federico A, Sapone A, Tuccillo C, Scialdone VR, Tiso A et al. Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage. Dig Liver Dis 2010; 42: 200-4.
107. Liu H, Zhang S, Yu A, Qu L, Zhao Y, Huang H et al. Studies on intestinal permeability of cirrhotic patients by analysis lactulose and mannitol in urine with HPLC/RID/MS. Bioorg Med Chem Lett 2004; 14: 2339-44.
108. Zhou Q, Zhang B, Verne GN. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome. Pain 2009; 146: 41-6.
109. Smecuol E, Sugai E, Niveloni S, Vázquez H, Pedreira S, Mazure R et al. Permeability, zonulin production, and enteropathy in dermatitis herpetiformis. Clin Gastroenterol Hepatol 2005; 3: 335-41.
110. Vilela E, Abreu Ferrari M, Gama Torres H, Martins F, Goulart E, Lima A et al. Intestinal permeability and antigliadin antibody test for monitoring adult patients with celiac disease. Dig Dis Sci 2007; 52: 1304-9.
111. Fries W, Renda MC, Lo Presti MA, Raso A, Orlando A, Oliva L et al. Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy. Am J Gastroenterol 2005; 100: 2730-6.
112. Benjamin J, Makharia GK, Ahuja V, Kalaivani M, Joshi YK. Intestinal permeability and its association with the patient and disease characteristics in Crohn s disease. World J Gastroenterol 2008; 14: 1399-405.
113. Braniste V, Leveque M, Buisson-Brenac C, Bueno L, Fioramonti J, Houdeau E. Oestradiol decreases colonic permeability through oestrogen receptor B-mediated up-regulation of occludin and junctional adhesion molecule-A in epithelial cells. J Physiol 2009; 587: 3317-28.
114. Homma H, Hoy E, Xu D-Z, Lu Q, Feinman R, Deitch EA. The female intestine is more resistant than the male intestine to gut injury and inflammation when subjected to conditions associated with shock states. Am J Physiol Gastrointest Liver Physiol 2005; 288: G466-G72.
115. Li Q, Zhang Q, Wang M, Zhao S, Ma J, Luo N et al. Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction. Clin Immunol 2008; 126: 67-80.
116. Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR. Interferon-TTand Tumor necrosis factor-aasynergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 2005; 166: 409-19.
117. Ye D, Guo S, Al-Sadi R, Ma TY. MicroRNA Regulation of intestinal epithelial tight junction permeability. Gastroenterology 2011; 141: 1323-33.
118. Forbes EE, Groschwitz K, Abonia JP, Brandt EB, Cohen E, Blanchard C et al. IL-9-and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med 2008; 205: 897-913.
119. Parodi A, Lauritano EC, Nardone G, Fontana L, Savarino V, Gasbarrini A. Small intestinal bacterial overgrowth. Dig Liver Dis Suppl 2009; 3: 44-9.
120. Wang Y, Liu Y, Sidhu A, Ma Z, McClain C, Feng W. Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. Am J Physiol Gastrointest Liver Physiol 2012; 303: G32-G41.
121. Zareie M, Johnson-Henry K, Jury J, Yang P-C, Ngan B-Y, Mc-Kay DM et al. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 2006; 55: 1553-60.
122. Liu Z, Zhang P, Ma Y, Chen H, Zhou Y, Zhang M et al. Lactobacillus plantarum prevents the development of colitis in IL-10-deficient mouse by reducing the intestinal permeability. Mol Bio Rep 2011; 38: 1353-61.
123. Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003; 52: 988-97.
124. Resta-Lenert S, Barrett KE. Probiotics and commensals reverse TNF-alpha-and IFN-gamma-induced dysfunction in human intestinal epithelial cells. Gastroenterology 2006; 130: 731-46.
125. Fedwick JP, Lapointe TK, Meddings JB, Sherman PM, Buret AG. Helicobacter pylori activates myosin ligt-chain kinase to disrupt claudin-4 and claudin-5 and increase epithelial permeability. Infect Immun 2005; 73: 7844-52.
126. Osanai M, Nishikiori N, Murata M, Chiba H, Kojima T, Sawada N. Cellular Retinoic Acid Bioavailability Determines Epithelial Integrity: Role of Retinoic Acid Receptor IIAgonists in Colitis. Mol Pharmacol 2007; 71: 250-8.
127. Sturniolo GC, Di Leo V, Ferronato A, D'Odorico A, D'Incà R. Zinc supplementation tightens "Leaky Gut" in Crohn's disease. Inflamm Bowel Dis 2001; 7: 94-8.
128. Chen P, Soares AM, Lima AAM, Gamble MV, Schorling JB, Conway M et al. Association of vitamin A and zinc status with altered intestinal permeability: analyses of cohort data from northeastern Brazil. JHPN 2003; 21: 309-15.
129. Zhong W, Zhao Y, McClain CJ, Kang YJ, Zhou Z. Inactivation of hepatocyte nuclear factor-4ttmediates alcohol-induced downregulation of intestinal tight junction proteins. Am J Physiol Gastrointest Liver Physiol 2010; 299: G643-G51.
130. Willemsen LM, Koetsier M, Balvers M, Beermann C, Stahl B, Tol EF. Polyunsaturated fatty acids support epithelial barrier integrity and reduce IL-4 mediated permeability in vitro. Eur J Nutr 2008; 47: 183-91.
131. Li Q, Zhang Q, Wang M, Zhao S, Xu G, Li J. n-3 polyunsaturated fatty acids prevent disruption of epithelial barrier function induced by proinflammatory cytokines. Mol Immunol 2008; 45: 1356-65.
132. Kong J, Zhang Z, Musch MW, Ning G, Sun J, Hart J et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 2008; 294: G208-G16.
133. Pachikian BD, Neyrinck AM, Deldicque L, De Backer FC, Catry E, Dewulf EM et al. Changes in Intestinal bifidobacteria levels are associated with the inflammatory response in magnesium-deficient mice. J Nutr 2010; 140: 509-14.
134. Mazzon E, Sturniolo GC, Puzzolo D, Frisina N, Fries W. Effect of stress on the paracellular barrier in the rat ileum. Gut 2002; 51: 507-13.
135. Boudry G, Jury J, Yang PC, Perdue MH. Chronic psychological stress alters epithelial cell turn-over in rat ileum. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1228-G32.
136. Suzuki T, Hara H. Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr Metab 2010; 7: 19.
137. Stenman LK, Holma R, Korpela R. High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. World J Gastroenterol 2012; 18: 923-9.
138. Gao Y, He L, Katsumi H, Sakane T, Fujita T, Yamamoto A. Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: Intestinal mucosal toxicity and absorption-enhancing mechanism of spermine. Int J Pharm 2008; 354: 126-34.
139. Frias R, Strube K, Ternes W, Collado MC, Spillmann T, Sankari S et al. Comparison of 51Chromium-labeled ethylenediamine tetra-acetic acid and iohexol as blood markers for intestinal permeability testing in Beagle dogs. Vet J 2012; 192: 123-5.
140. Andersen R, Stordahl A, Aase S, Laerum F. Intestinal permeability of X-ray contrast media iodixanol and iohexol during bacterial overgrowth of small intestines in rats. Dig Dis Sci 2001; 46: 208-13.
141. Paseephol T, Small DM, Sherkat F. Lactulose production from milk concentration permeate using calcium carbonate-based catalysts. Food Chem 2008; 111: 283-90.
142. Olano A, Corzo N. Lactulose as a food ingredient. J Sci Food Agric 2009; 89: 1987-90.
143. Rupérez P, Toledano G. Celery by-products as a source of mannitol. Eur Food Res Technol 2003; 216: 224-6.
144. Stoop JMH, Williamson JD, Mason Pharr D. Mannitol metabolism in plants: a method for coping with stress. Trends Plant Sci 1996; 1: 139-44.
145. Mäkinen KK, Söderllng EVA. A quantitative study of mannitol, sorbitol, xylitol, and xylose in wild berries and commercial fruits. J Food Sci 1980; 45: 367-71.
146. Binns NM. Sucralose-all sweetness and light. Nutr Bull 2003; 28: 53-8.